The primary objective of the study is to evaluate that 3 immunosuppressant regimens will have comparable kidney function results in kidney transplant patients.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
342
Calculated glomerular filtration rate after 12 months treatment
Incidence of death, graft loss, biopsy-proven acute rejection after 3 and 12 months.
Patient and graft survival after 12 months.
Incidence of AEs and SAEs after 3 and 12 months.
Blood pressure, lipids and glucose profiles after 3 and 12 months.
Percentage of patients free of steroids at 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
UCSF Kidney Transplant Service
San Francisco, California, United States
Livelink, Inc.
Tampa, Florida, United States
Loyola Medical Center
Maywood, Illinois, United States
Indiana U. Medical Center
Indianapolis, Indiana, United States
University of Michigan Health System
Ann Arbor, Michigan, United States
University Hospitals of Cleveland, Division of Nephrology
Cleveland, Ohio, United States
Ohio State University Medical Center
Columbus, Ohio, United States
Legacy Research & Technology Ctr.
Portland, Oregon, United States
U. of Wisconsin Hospital Clinics
Madison, Wisconsin, United States
Crai Norte
San Martín, Buenos Aires, Argentina
...and 34 more locations